glp-1 and low blood pressure Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Control GLP-1 and High Blood Pressure:

First, and most obviously, GLP-1 may emerge as a promising candidate biomarker for the early detection of gut injury in humans, while also representing a novel therapeutic target for the control of inflammation in the gut

Glutathione in the brain: Disorders of glutathione metabolism

Heart rate changes by dose group At the 12 mg dose (the highest tested), the average heart rate increase peaked at approximately 6.7 beats per minute at week 24

GLP-1RA therapy converges on this oxidative axis but uniquely couples it with sustained hypophagia and reduced exogenous nutrient inflow

Akt and mTOR in B cell activation and differentiation